On Friday, Cg Oncology Inc (NASDAQ: CGON) was -7.34% drop from the session before settling in for the closing price of $35.50. A 52-week range for CGON has been $25.77 – $50.23.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
A company in the Healthcare sector has dropped its sales by -45.67% annually for the last half of the decade. When this article was written, the company’s average yearly earnings per share was at -14.41%. With a float of $40.23 million, this company’s outstanding shares have now reached $66.64 million.
In an organization with 61 employees, it is important to assess its efficiency. In terms of profitability, gross margin is 97.69%, operating margin of -12572.31%, and the pretax margin is -9870.31%.
Cg Oncology Inc (CGON) Insider Updates
Also, it is sometimes useful to examine the sentiment of large-scale investors toward Cg Oncology Inc stocks. The insider ownership of Cg Oncology Inc is 40.02%, while institutional ownership is 62.23%. The most recent insider transaction that took place on Aug 29 ’24, was worth 23,000,089. In this transaction Director of this company sold 650,455 shares at a rate of $35.36, taking the stock ownership to the 586,982 shares. Before that another transaction happened on Aug 29 ’24, when Company’s Director proposed sale 424,210 for $35.36, making the entire transaction worth $15,000,000.
Cg Oncology Inc (CGON) Performance Highlights and Predictions
According to the Wall Street analysts, stocks earnings will be around -14.41% per share during the next fiscal year.
Cg Oncology Inc (NASDAQ: CGON) Trading Performance Indicators
You can see what Cg Oncology Inc (CGON) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 35.32. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 3031.52.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.28, a number that is poised to hit -0.36 in the next quarter and is forecasted to reach -1.83 in one year’s time.
Technical Analysis of Cg Oncology Inc (CGON)
Let’s dig in a bit further. During the last 5-days, its volume was 0.59 million. That was inferior than the volume of 0.65 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 6.20%. Additionally, its Average True Range was 1.80.
During the past 100 days, Cg Oncology Inc’s (CGON) raw stochastic average was set at 33.96%, which indicates a significant increase from 4.58% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 55.43% in the past 14 days, which was higher than the 48.25% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $36.70, while its 200-day Moving Average is $36.43. However, in the short run, Cg Oncology Inc’s stock first resistance to watch stands at $34.97. Second resistance stands at $37.05. The third major resistance level sits at $38.27. If the price goes on to break the first support level at $31.67, it is likely to go to the next support level at $30.45. Assuming the price breaks the second support level, the third support level stands at $28.37.
Cg Oncology Inc (NASDAQ: CGON) Key Stats
There are 67,630K outstanding shares of the company, which has a market capitalization of 2.06 billion. As of now, sales total 200 K while income totals -48,610 K. Its latest quarter income was 110 K while its last quarter net income were -18,900 K.
